Clinical Trials on Genitale Neubildungen, weiblich

Total 12999 results

BioNTech SE

Recruiting

A Clinical Trial in Healthy Volunteers to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions

Genital Herpes Simplex Type 2

United States
GlaxoSmithKline

Active, not recruiting

A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes

Herpes Simplex

Germany, United States, Belgium, Canada, Spain, United Kingdom, Estonia, Australia
Assembly Biosciences

Not yet recruiting

A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes

Recurrent Genital Herpes Simplex Type 2

New Zealand
Kaiser Permanente
Patient-Centered Outcomes Research Institute

Recruiting

Treating Genital Herpes Infection to Reduce Racial Disparities in the Risk of Severe Maternal Morbidity (PCORISMM)

Maternal Morbidity | Racial Disparities | Genital Herpes Simplex

United States
ModernaTX, Inc.

Active, not recruiting

A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes

Genital Herpes

United States
Labo'Life

Terminated

Study of 2LHERP® in Genital Herpes Infections (HEARTH-GEN)

Herpes Simplex, Genital

Belgium
Starpharma Pty Ltd
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.

HIV Infections | HSV-2 Genital Herpes

Australia
UBP Greater China (Shanghai) Co., Ltd

Not yet recruiting

UB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the Genitals

Recurrent Genital Herpes
UBP Greater China (Shanghai) Co., Ltd

Not yet recruiting

Evaluating Safety and Efficacy of Repeat Doses of UB-621in Adult Patients With Recurrent Genital Herpes

Recurrent Genital Herpes
EMS

Completed

Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes

GENITAL HERPES

Brazil
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Acyclovir Therapy for Genital Herpes Ulcers in HIV Negative African Women

Ulcers of Female Genital Organs

Zambia
GlaxoSmithKline

Active, not recruiting

An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.

Herpes Genitalis

United States, France, Italy, Spain, Finland, United Kingdom
Sharon Achilles

Completed

Study of Immune Cell Changes in the Genital Tract 2 Months After Initiation of an IUD for Contraception (CHIC)

Genital Tract Mucosal Immunity | Genital Tract Microflora

United States
Genocea Biosciences, Inc.

Completed

Evaluating New Formulation of Therapeutic HSV-2 Vaccine

Genital Herpes Simplex Type 2

United States
Genocea Biosciences, Inc.

Completed

Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity

Genital Herpes Simplex Type 2

United States
Genocea Biosciences, Inc.

Completed

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

Genital Herpes Simplex Type 2

United States
Genocea Biosciences, Inc.

Completed

Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study

Genital Herpes Simplex Type 2

United States
Genocea Biosciences, Inc.

Completed

Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine

Genital Herpes Simplex Type 2

United States
Vical

Completed

Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

Genital Herpes Simplex Type 2

United States
Piazza della Vittoria 14 Studio Medico - Ginecologia...

Completed

Knowledge and Perspective of Healthcare Professionals About Female Genital Mutation (FMG-HCPROF)

Female Genital Mutilation Type I Status | Female Genital Mutilation Type II Status | Female Genital Mutilation Type III Status

Italy
Novartis

Completed

Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes

Recurrent Genital Herpes

Australia
Arizona State University
Catholic Charities Phoenix; Phoenix International Refugee Committee; Refugee... and other collaborators

Completed

Female Genital Cutting in the Arizona Somali Refugee Community (FGC)

Female Genital Mutilation Type I Status | Female Genital Mutilation Type II Status | Female Genital Mutilation Type III Status

United States
M.D. Anderson Cancer Center
Janssen-Cilag div. of Johnson&Johnson SE

Withdrawn

Neoadjuvant Listeria or Daratumumab in Prostate Cancer

Prostate Cancer | Malignant Neoplasms of Male Genital Organs
United BioPharma

Not yet recruiting

A Phase 2 Trial to Evaluate the Safety and Efficacy of UB-621

Genital Herpes
University of Washington
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Effect of HSV-2 Suppressive Therapy on Sexual Behavior

Genital Herpes

United States
GlaxoSmithKline

Completed

Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)

Genital Herpes
AiCuris Anti-infective Cures AG
Medpace, Inc.

Terminated

Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes

Genital Herpes

United States
University of Washington
National Institutes of Health (NIH)

Completed

HSV-2 Shedding Resolution After Acyclovir Treatment

Genital Herpes

United States
Agenus Inc.

Completed

Trial Evaluating Safety, Tolerability and Immune Response of AG-707

Genital Herpes

United States
Novartis

Completed

RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir

Recurrent Genital Herpes (RGH)

United States
Assiut University

Not yet recruiting

Consequences of Female Genital Mutilation on Married Women.

Female Genital Mutilation
Genewel Co., Ltd

Unknown

Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy (GUARDIX-FL)

Genital Diseases, Female

Korea, Republic of
University of Washington
GlaxoSmithKline

Completed

Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

Genital Herpes

United States
University of Washington
National Institutes of Health (NIH)

Completed

A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation

Genital Herpes

United States
Rational Vaccines Inc

Completed

A Study of the Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease

Patient Engagement | Genital Herpes

United Kingdom
University of Washington

Completed

Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2

Genital Herpes

United States
Stony Brook University

Completed

HSV Seroprevalence and Diagnosis of Genital Herpes in Pregnant Women

Pregnancy

United States
Beni-Suef University

Unknown

PREVALENCE OF FEMALE GENITAL MUTILATION IN BENI-SUEF LOCALITIES

Female Genital Mutilation

Egypt
PowderMed

Completed

Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2

HSV-2

United States
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC

Completed

Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis

Malignant Neoplasms of Male Genital Organs

United States
M.D. Anderson Cancer Center
AstraZeneca

Active, not recruiting

Selumetinib and Olaparib in Solid Tumors

Malignant Neoplasms of Female Genital Organs | Malignant Neoplasm of Breast | Malignant Neoplasms of Thyroid and Other Endocrine Glands | Malignant Neoplasms of Digestive Organs | Malignant Neoplasms of Male Genital Organs

United States
Karolinska Institutet
Region Skane

Recruiting

SMS-based Summons in Cervical Screening

Neoplasms | Neoplasms by Site | Cervical Cancer | Uterine Neoplasms | Uterine Diseases | Genital Diseases, Female | Uterine Cervical Neoplasm | Uterine Cervical Disease | Genital Neoplasm, Female | Genital Neoplasm

Sweden
The University of Texas Medical Branch, Galveston
M.D. Anderson Cancer Center; The University of Texas Health Science Center,... and other collaborators

Active, not recruiting

Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande Valley

Malignant Neoplasms of Female Genital Organs

United States
CLJI Worldwide
UMC Utrecht; University of Washington; University of Rotterdam, The Netherlands; Applied Clinical Services... and other collaborators

Completed

The VIBLOK SAfety and perFormancE Trial (SAFE)

Genital Herpes | HSV-2 Infection

Netherlands
Ottawa Hospital Research Institute
Knight Therapeutics (USA) Inc

Recruiting

Dose Escalation For INtraprostatic LEsions (DEFINE)

Prostatic Neoplasms

Canada
Hospices Civils de Lyon
EDAP TMS S.A.

Recruiting

Evaluation of Different Methods of Ultrasound Image Analysis for Real-time Monitoring of HIFU Prostate Cancer Treatment (ELASTO-US)

Prostatic Neoplasms

France
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

The Application Value of 18F-prostate-specific Membrane Antigen PET/CT in Prostate Cancer

Prostatic Neoplasms

China
Celgene

Recruiting

Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms

United States
Aragon Pharmaceuticals, Inc.

Active, not recruiting

An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS

Prostatic Neoplasms

United States, France, Poland, Taiwan, Ukraine, United Kingdom, China, Belgium, Germany, Spain, Israel, Mexico, Malaysia, Romania, Turkey, Canada, Netherlands, Korea, Republic of, Brazil, Russian Federation, Argentina, Sweden, Czechia
Janssen Research & Development, LLC

Active, not recruiting

A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)

Prostatic Neoplasms

China

Clinical Trials on Genitale Neubildungen, weiblich

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations